Followers | 8 |
Posts | 147 |
Boards Moderated | 0 |
Alias Born | 06/17/2013 |
Tuesday, March 03, 2015 2:06:44 PM
On 9/10 PR stated: 'The Company was informed that before it is cleared to initiate a clinical trial, it must submit additional safety data from experiments conducted in a GLP certified laboratory'.
On 1/14 PR stated: 'Currently FDA is reviewing protocols submitted by the Company for conducting an additional GLP safety study before clinical trials can begin'.
That 1/14 PR is almost 2 months old. I don't see any other company information regarding HemaXellerate since 1/14.
In those 2 months that have passed, do you think it's possible protocol has been approved and those GLP tests are underway as of today? My thought is the company wouldn't announce that they were, as although that may indicate progress to some, most investors would just view it as another fluff PR. Perhaps this is closer than one may think given some of the other events that have happened since the 1/14 PR.
I don't know either way, but I'm just thinking (or hoping) RGBP is closer than you infer. Thoughts?
FEATURED North Bay Resources Announces Federal (MSHA) Approval of Mt. Vernon Gold Mine Operational Plan and Commencement of Production, Sierra County, California • Oct 21, 2024 9:00 AM
Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development • HYDI • Oct 21, 2024 9:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM